This study indicates that anti-PD-L1 + SDT is effective in reducing both tumor volume and metastatic lung nodules, as well as increasing CD8+T effector cells, suggesting the combination of anti-PD-L1 + SDT can have a significant antitumor effect. Here, CD274 is linked to neoplasm.